As we mentioned a few weeks ago, we welcomed our first Calmare Therapy patient from Europe (Amsterdam) this week who is undergoing treatment to combat chronic bilateral foot pain as a result of chemotherapy-induced peripheral neuropathy, or CIPN. As we and others have shared in the past, CIPN pain is notoriously difficult to treat successfully.
Our patient contracted CIPN three months after undergoing chemotherapy for breast cancer more than three years ago. Her pain level escalated to a seven and she began having difficulty walking. She is undergoing 10 Calmare treatments and her outcome looks very positive. We look forward to sharing her outcome as she therapy progresses.
Dr. Michael Cooney